Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Human Genetics01:28

Human Genetics

797
Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
797
Drugs Affecting Neurotransmitter Synthesis01:29

Drugs Affecting Neurotransmitter Synthesis

1.7K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.7K
Drugs Affecting Neurotransmitter Release or Uptake01:21

Drugs Affecting Neurotransmitter Release or Uptake

1.3K
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
1.3K
Attention-Deficit/Hyperactivity Disorder01:30

Attention-Deficit/Hyperactivity Disorder

423
Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
423
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists01:30

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

232
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
232
Biological Influences on Intelligence01:30

Biological Influences on Intelligence

260
Intelligence is often thought to be linked to brain size, but the relationship is more complex than that. While brain size does correlate modestly with some abilities, like verbal skills, the connection is weaker for others, such as spatial reasoning. Other factors, like brain structure, also play crucial roles. For instance, despite Einstein's smaller-than-average brain, his parietal cortex, which is involved in spatial reasoning, was 15% wider, suggesting that neural density might matter...
260

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Set-shifting and task-switching make differential contributions to divergent thinking in adolescence.

BMC psychology·2026
Same author

Visual attention is linked to temporally structured noradrenaline release in the medial prefrontal cortex.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology·2026
Same author

Social reward outcompetes drug seeking dopaminergic ensembles to prevent relapse.

Nature communications·2026
Same author

From chronic pain to depression: Neurogenesis-driven microglial remodeling in the hippocampal dentate gyrus.

Science (New York, N.Y.)·2026
Same author

Computational modelling identifies key determinants of subregion-specific dopamine dynamics in the striatum.

eLife·2026
Same author

Downregulation of integrin α3 in ADHD mirrored in mutant mouse model by dopamine-dependent hippocampal AMPAR expression.

Molecular psychiatry·2025

Related Experiment Video

Updated: Oct 12, 2025

Developing a Rat Model for Bipolar Disorder
04:42

Developing a Rat Model for Bipolar Disorder

Published on: May 2, 2025

615

Dopamine, Cognitive Flexibility, and IQ: Epistatic Catechol-O-MethylTransferase:DRD2 Gene-Gene Interactions Modulate

Leor Zmigrod1, Trevor W Robbins1

  • 1University of Cambridge.

Journal of Cognitive Neuroscience
|November 24, 2021
PubMed
Summary

High intelligence may compensate for dopamine gene effects on cognitive flexibility. Gene interactions reveal dopamine system redundancy, impacting adaptable thought and action.

More Related Videos

Automated, Long-term Behavioral Assay for Cognitive Functions in Multiple Genetic Models of Alzheimer's Disease, Using IntelliCage
06:46

Automated, Long-term Behavioral Assay for Cognitive Functions in Multiple Genetic Models of Alzheimer's Disease, Using IntelliCage

Published on: August 4, 2018

12.3K
Chemogenetic Regulation in Reprogrammed Stem Cell-derived Precursor Cells in Treating Neurodegenerative Diseases
09:44

Chemogenetic Regulation in Reprogrammed Stem Cell-derived Precursor Cells in Treating Neurodegenerative Diseases

Published on: May 2, 2025

365

Related Experiment Videos

Last Updated: Oct 12, 2025

Developing a Rat Model for Bipolar Disorder
04:42

Developing a Rat Model for Bipolar Disorder

Published on: May 2, 2025

615
Automated, Long-term Behavioral Assay for Cognitive Functions in Multiple Genetic Models of Alzheimer's Disease, Using IntelliCage
06:46

Automated, Long-term Behavioral Assay for Cognitive Functions in Multiple Genetic Models of Alzheimer's Disease, Using IntelliCage

Published on: August 4, 2018

12.3K
Chemogenetic Regulation in Reprogrammed Stem Cell-derived Precursor Cells in Treating Neurodegenerative Diseases
09:44

Chemogenetic Regulation in Reprogrammed Stem Cell-derived Precursor Cells in Treating Neurodegenerative Diseases

Published on: May 2, 2025

365

Area of Science:

  • Neuroscience
  • Behavioral Genetics
  • Cognitive Psychology

Background:

  • Cognitive flexibility is linked to dopamine neurotransmission, but gene associations remain unclear.
  • Previous studies have suffered from small sample sizes and conflicting results.
  • Gene-gene interactions in dopamine pathways are understudied in relation to cognitive flexibility.

Purpose of the Study:

  • To investigate the role of specific dopamine gene polymorphisms in cognitive flexibility.
  • To examine gene-gene interactions influencing cognitive flexibility.
  • To explore the moderating effect of intelligence on genetic influences on cognitive flexibility.

Main Methods:

  • A large neurocognitive-genetic study (n=1400) using the Wisconsin Card Sorting Test.
  • Analysis of single nucleotide polymorphisms (SNPs) in catechol-O-methyltransferase (COMT; rs4680) and C957T (rs6277).
  • Investigation of gene-gene interactions, including with DRD2, and their interplay with participant IQ.

Main Results:

  • COMT (rs4680) and C957T (rs6277) polymorphisms impacted cognitive flexibility, but only in low-IQ individuals.
  • High intelligence appeared to compensate for, and mask, the effects of these dopamine gene variants.
  • Epistatic redundancy was observed between COMT and DRD2, where combined genotypes supported flexibility, but neither was individually necessary.

Conclusions:

  • Intelligence moderates the impact of dopamine gene variants on cognitive flexibility.
  • Dopamine systems exhibit epistatic redundancy, highlighting substitutability in flexible cognition.
  • Findings offer insights into clinical disorders, psychopharmacology, and fronto-striatal interactions in cognition.